PUBLISHER: Stratistics Market Research Consulting | PRODUCT CODE: 1126504
PUBLISHER: Stratistics Market Research Consulting | PRODUCT CODE: 1126504
Drug Discovery Market Forecasts to 2028 - Global Analysis by Technology, Service, Process, Therapeutic Area, End Use and By Geography
According to Stratistics MRC, the Global Drug Discovery Market is accounted for $47.38 billion in 2022 and is expected to reach $84.86 billion by 2028 growing at a CAGR of 10.2% during the forecast period. In the fields of medicine, biotechnology, and pharmacology, novel candidate medicines are found through the process of drug discovery. In the past, drugs were discovered by accident, as was the case with penicillin, or by identifying the active component in conventional treatments. A technique known as classical pharmacology involved screening chemical libraries of created small molecules, natural products, or extracts in whole cells or organisms to find substances that had desired therapeutic effects.
According to Cardiovascular diseases (CVDs) key facts published by the World Health Organization in June 2021, CVDs are the leading cause of death globally, representing around 32% of all global deaths. According to the American Cancer Society, in 2020, about 1.8 million new cancer cases were expected to be diagnosed and approximately 606,520 cancer deaths may have occurred in the United States. Thus, the increasing burden of a diverse range of diseases among all age groups and its burden, globally, drive the demand for drug discovery and its market.
Market Dynamics:
Driver:
Profound Impact of Oncology on Market Growth
Oncology's use of AI is thought to have tremendous growth potential. Researchers can design new therapies and modify drug use by better understanding how cancer cells develop resistance to anticancer medications with the aid of artificial intelligence (AI). Current research on anticancer drugs can be accelerated by AI technology like machine learning. A prime example of recent developments in the oncology sector is Paige's, a start-up that develops AI diagnostic technology. Through the application of machine learning, the business enables pathologists to accurately diagnose cancer using photographs of tissue samples.
Restraint:
Stringent regulations governing drug discovery and animal usage
During the drug approval process, regulatory agencies' main priorities are safety and efficacy. This aspect can have a considerable impact on the uptake of a certain treatment in emerging markets that are price sensitive. In addition, a number of laws that guarantee the quality of the product (such GMP) frequently raise the cost of manufacturing. The use of animals in the drug discovery process is governed by strict regulations. The most often employed animals in study are mice, rats, fish, amphibians, and reptiles. Governments have introduced rules for animal safety and use in response to ethical questions about this practise, which poses a number of difficulties for drug discovery research. Due to this, businesses are now using alternative methods to reduce the use of animals.
Opportunity:
Advancements in Treatment of Neurological Diseases to Open Profitable Avenues
Numerous prospects for growth may arise from the use of AI to the treatment of neurological conditions. The pharmaceutical sector is working together to investigate new treatments for neurological illnesses. PharmEnable, a drug discovery company located in the UK, and Sosei, a company based in Japan, are working together to find drug leads using Sosei Heprares' CPCR-focused drug design platform and PharmEnable's AI technology. Similar breakthroughs will guarantee significant market growth for AI-based drug discovery.
Threat:
Shortage of Skilled Personnel
The R&D outsourcing market for pharmaceuticals, biotechnology, and medical devices is always changing. Professionals must deliver excellent services, adhere to proper laboratory practises, and stay up with the ongoing developments in pharmaceutical R&D technologies and processes. As they compete for competent and experienced scientists with pharmaceutical and biotechnology corporations, academic institutions, and research organisations, Contract Research Organization (CRO) confront difficulties in attracting and keeping highly skilled personnel. Companies must provide higher salaries and other perks in order to compete effectively; this may have an impact on the finances and business performance of competitors, particularly small-scale analytical testing suppliers.
COVID-19 Impact
Drug discovery and development for the treatment of COVID-19 are being performed by screening both novel and existing drugs for their potential to reduce symptoms and stop viral replication. During COVID-19 pandemic, the need for the development of a drug or vaccine is projected to have a positive impact on the drug discovery services market. In order to better identify drug candidates, future drug discovery technologies including high throughput, bioinformatics, and medicinal chemistry are increasingly being applied in the drug discovery services market. Drug development has significantly benefited from emerging technology, which has made it more sophisticated, accurate, and efficient.
The small molecule segment is expected to be the largest during the forecast period
The small molecule sector dominated the market in terms of drug type. This is a result of the population's rising need for small molecule medications. Because of their small size and weight, small molecule medications are able to treat diseases and easily affect cells. Therefore, the manufacturers' investments in the development of small molecule pharmaceuticals have increased as a result of the increased awareness of the usefulness of small molecule drugs.
The pharmaceutical corporations segment is expected to have the highest CAGR during the forecast period
The global market for drug discovery was dominated by pharmaceutical corporations. This is a result of leading pharmaceutical and biotechnology businesses investing more money in the creation of new medicines. The growing elderly population and incidence of chronic diseases are driving up demand for a wide range of cutting-edge medications. The global rise in drug demand has stimulated the market for drug discovery. As a result, pharmaceutical corporations segment is expected to have the highest CAGR during the forecast period.
Region with highest share:
The market for drug discovery globally was dominated by North America with largest share. In terms of global spending on research and development, the US holds the top spot. Furthermore, the majority of the recently developed new pharmaceuticals are protected by US patents. The rising frequency of chronic diseases has increased the demand for cutting-edge and novel medications, which has supported the expansion of the drug discovery market in North America. In the US, around half of the population has one or more chronic illnesses. As a result, the nation now spends a lot of money on healthcare. Additionally, the region's growing awareness of biologics is boosting the market's expansion.
Region with highest CAGR:
In the approaching years, it is predicted that Asia Pacific would offer the most opportunities. This can be linked to the region's abundance of Contract Research Organization (CRO). Additionally, some areas are making significant investments in the expansion of the pharmaceutical sector, which is driving up demand for biopharmaceutical goods. In addition, given older individuals are more sensitive to chronic diseases, it is anticipated that the region's growing elderly population would boost drug demand in the near future. Asia Pacific is expected to see the highest CAGR during the projection period.
Key players in the market
Some of the key players profiled in the Drug Discovery Market include Abbott Laboratories Inc., Charles River Laboratories International Inc., Astrazeneca plc, Bayer AG, Merck & Co. Inc., Eli Lilly and Company, Shimadzu Corp, F. Hoffmann-La Roche Ltd, GlaxoSmithKline PLC, Agilent Technologies Inc., Thermo Fisher Scientific Inc., Pfizer Inc., Novartis AG, Evotec SE, Icon PLC.
Key Developments:
In February 2022, Agilent Technologies Inc bought Virtual Control, an AI and machine learning Software Company, with the goal of obtaining innovative lab testing analytical solutions built by them. Agilent will use the software in its mass spectrometry (GS/MS) and gas chromatography platforms for improving efficiency, productivity, and accuracy.
In November 2020, Genesis Therapeutics entered AI-driven, multi-target drug discovery partnership with Genentech. The collaboration leverages Genesis' graph machine learning and drug discovery expertise to identify innovative drug candidates for therapeutic targets in multiple disease areas.
In January 2020, Bayer collaborated with Exscientia, an artificial intelligence drug discovery company, for the development of cardiovascular and oncology diseases related drug.
Drug Types Covered:
- Large Molecule
- Small Molecule
Technologies Covered:
- Nanotechnology
- High Throughput Screening
- Combinatorial Chemistry
- Pharmacogenomics
- Bioanalytical Instruments
- Biochips
- Bioinformatics
- Other Technologies
Services Covered:
- Medicinal Chemical Services
- Biological Services
- Drug Metabolism and Pharmacokinetics (DMPK) Services
- Other Services
Processes Covered:
- Target Selection
- Target Validation
- Hit-To-Lead Identification
- Lead Optimization
- Candidate Validation
Therapeutic Areas Covered:
- Respiratory Disease
- Neurology
- Infectious and Immune System Diseases
- Oncology
- Cardiovascular Diseases
- Digestive System Diseases
- Diabetes
- Other Therapeutic Areas
End Users Covered:
- Pharmaceutical Companies
- Contract Research Organization (CRO)
- Research Institutes
- Other End Users
Regions Covered:
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- Italy
- France
- Spain
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia
- New Zealand
- South Korea
- Rest of Asia Pacific
- South America
- Argentina
- Brazil
- Chile
- Rest of South America
- Middle East & Africa
- Saudi Arabia
- UAE
- Qatar
- South Africa
- Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2020, 2021, 2022, 2025, and 2028
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
- Company Profiling
- Comprehensive profiling of additional market players (up to 3)
- SWOT Analysis of key players (up to 3)
- Regional Segmentation
- Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
- Competitive Benchmarking
- Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Table of Contents
1 Executive Summary
2 Preface
- 2.1 Abstract
- 2.2 Stake Holders
- 2.3 Research Scope
- 2.4 Research Methodology
- 2.4.1 Data Mining
- 2.4.2 Data Analysis
- 2.4.3 Data Validation
- 2.4.4 Research Approach
- 2.5 Research Sources
- 2.5.1 Primary Research Sources
- 2.5.2 Secondary Research Sources
- 2.5.3 Assumptions
3 Market Trend Analysis
- 3.1 Introduction
- 3.2 Drivers
- 3.3 Restraints
- 3.4 Opportunities
- 3.5 Threats
- 3.6 End User Analysis
- 3.7 Emerging Markets
- 3.8 Impact of Covid-19
4 Porters Five Force Analysis
- 4.1 Bargaining power of suppliers
- 4.2 Bargaining power of buyers
- 4.3 Threat of substitutes
- 4.4 Threat of new entrants
- 4.5 Competitive rivalry
5 Global Drug Discovery Market, By Drug Type
- 5.1 Introduction
- 5.2 Large Molecule
- 5.3 Small Molecule
6 Global Drug Discovery Market, By Technology
- 6.1 Introduction
- 6.2 Nanotechnology
- 6.3 High Throughput Screening
- 6.4 Combinatorial Chemistry
- 6.5 Pharmacogenomics
- 6.6 Bioanalytical Instruments
- 6.7 Biochips
- 6.8 Bioinformatics
- 6.9 Other Technologies
7 Global Drug Discovery Market, By Service
- 7.1 Introduction
- 7.2 Medicinal Chemical Services
- 7.3 Biological Services
- 7.4 Drug Metabolism and Pharmacokinetics (DMPK) Services
- 7.5 Other Services
8 Global Drug Discovery Market, By Process
- 8.1 Introduction
- 8.2 Target Selection
- 8.3 Target Validation
- 8.4 Hit-To-Lead Identification
- 8.5 Lead Optimization
- 8.6 Candidate Validation
9 Global Drug Discovery Market, By Therapeutic Area
- 9.1 Introduction
- 9.2 Respiratory Disease
- 9.3 Neurology
- 9.4 Infectious and Immune System Diseases
- 9.5 Oncology
- 9.6 Cardiovascular Diseases
- 9.7 Digestive System Diseases
- 9.8 Diabetes
- 9.9 Other Therapeutic Areas
10 Global Drug Discovery Market, By End User
- 10.1 Introduction
- 10.2 Pharmaceutical Companies
- 10.3 Contract Research Organization (CRO)
- 10.4 Research Institutes
- 10.5 Other End Users
11 Global Drug Discovery Market, By Geography
- 11.1 Introduction
- 11.2 North America
- 11.2.1 US
- 11.2.2 Canada
- 11.2.3 Mexico
- 11.3 Europe
- 11.3.1 Germany
- 11.3.2 UK
- 11.3.3 Italy
- 11.3.4 France
- 11.3.5 Spain
- 11.3.6 Rest of Europe
- 11.4 Asia Pacific
- 11.4.1 Japan
- 11.4.2 China
- 11.4.3 India
- 11.4.4 Australia
- 11.4.5 New Zealand
- 11.4.6 South Korea
- 11.4.7 Rest of Asia Pacific
- 11.5 South America
- 11.5.1 Argentina
- 11.5.2 Brazil
- 11.5.3 Chile
- 11.5.4 Rest of South America
- 11.6 Middle East & Africa
- 11.6.1 Saudi Arabia
- 11.6.2 UAE
- 11.6.3 Qatar
- 11.6.4 South Africa
- 11.6.5 Rest of Middle East & Africa
12 Key Developments
- 12.1 Agreements, Partnerships, Collaborations and Joint Ventures
- 12.2 Acquisitions & Mergers
- 12.3 New Product Launch
- 12.4 Expansions
- 12.5 Other Key Strategies
13 Company Profiling
- 13.1 Abbott Laboratories Inc.
- 13.2 Charles River Laboratories International Inc.
- 13.3 Astrazeneca plc
- 13.4 Bayer AG
- 13.5 Merck & Co. Inc.
- 13.6 Eli Lilly and Company
- 13.7 Shimadzu Corp
- 13.8 F. Hoffmann-La Roche Ltd
- 13.9 GlaxoSmithKline PLC
- 13.10 Agilent Technologies Inc.
- 13.11 Thermo Fisher Scientific Inc.
- 13.12 Pfizer Inc.
- 13.13 Novartis AG
- 13.14 Evotec SE
- 13.15 Icon PLC
List of Tables
- Table 1 Global Drug Discovery Market Outlook, By Region (2020-2028) ($MN)
- Table 2 Global Drug Discovery Market Outlook, By Drug Type (2020-2028) ($MN)
- Table 3 Global Drug Discovery Market Outlook, By Large Molecule (2020-2028) ($MN)
- Table 4 Global Drug Discovery Market Outlook, By Small Molecule (2020-2028) ($MN)
- Table 5 Global Drug Discovery Market Outlook, By Technology (2020-2028) ($MN)
- Table 6 Global Drug Discovery Market Outlook, By Nanotechnology (2020-2028) ($MN)
- Table 7 Global Drug Discovery Market Outlook, By High Throughput Screening (2020-2028) ($MN)
- Table 8 Global Drug Discovery Market Outlook, By Combinatorial Chemistry (2020-2028) ($MN)
- Table 9 Global Drug Discovery Market Outlook, By Pharmacogenomics (2020-2028) ($MN)
- Table 10 Global Drug Discovery Market Outlook, By Bioanalytical Instruments (2020-2028) ($MN)
- Table 11 Global Drug Discovery Market Outlook, By Biochips (2020-2028) ($MN)
- Table 12 Global Drug Discovery Market Outlook, By Bioinformatics (2020-2028) ($MN)
- Table 13 Global Drug Discovery Market Outlook, By Other Technologies (2020-2028) ($MN)
- Table 14 Global Drug Discovery Market Outlook, By Service (2020-2028) ($MN)
- Table 15 Global Drug Discovery Market Outlook, By Medicinal Chemical Services (2020-2028) ($MN)
- Table 16 Global Drug Discovery Market Outlook, By Biological Services (2020-2028) ($MN)
- Table 17 Global Drug Discovery Market Outlook, By Drug Metabolism and Pharmacokinetics (DMPK) Services (2020-2028) ($MN)
- Table 18 Global Drug Discovery Market Outlook, By Other Services (2020-2028) ($MN)
- Table 19 Global Drug Discovery Market Outlook, By Process (2020-2028) ($MN)
- Table 20 Global Drug Discovery Market Outlook, By Target Selection (2020-2028) ($MN)
- Table 21 Global Drug Discovery Market Outlook, By Target Validation (2020-2028) ($MN)
- Table 22 Global Drug Discovery Market Outlook, By Hit-To-Lead Identification (2020-2028) ($MN)
- Table 23 Global Drug Discovery Market Outlook, By Lead Optimization (2020-2028) ($MN)
- Table 24 Global Drug Discovery Market Outlook, By Candidate Validation (2020-2028) ($MN)
- Table 25 Global Drug Discovery Market Outlook, By Therapeutic Area (2020-2028) ($MN)
- Table 26 Global Drug Discovery Market Outlook, By Respiratory Disease (2020-2028) ($MN)
- Table 27 Global Drug Discovery Market Outlook, By Neurology (2020-2028) ($MN)
- Table 28 Global Drug Discovery Market Outlook, By Infectious and Immune System Diseases (2020-2028) ($MN)
- Table 29 Global Drug Discovery Market Outlook, By Oncology (2020-2028) ($MN)
- Table 30 Global Drug Discovery Market Outlook, By Cardiovascular Diseases (2020-2028) ($MN)
- Table 31 Global Drug Discovery Market Outlook, By Digestive System Diseases (2020-2028) ($MN)
- Table 32 Global Drug Discovery Market Outlook, By Diabetes (2020-2028) ($MN)
- Table 33 Global Drug Discovery Market Outlook, By Other Therapeutic Areas (2020-2028) ($MN)
- Table 34 Global Drug Discovery Market Outlook, By End User (2020-2028) ($MN)
- Table 35 Global Drug Discovery Market Outlook, By Pharmaceutical Companies (2020-2028) ($MN)
- Table 36 Global Drug Discovery Market Outlook, By Contract Research Organization (CRO) (2020-2028) ($MN)
- Table 37 Global Drug Discovery Market Outlook, By Research Institutes (2020-2028) ($MN)
- Table 38 Global Drug Discovery Market Outlook, By Other End Users (2020-2028) ($MN)
- Table 39 North America Drug Discovery Market Outlook, By Country (2020-2028) ($MN)
- Table 40 North America Drug Discovery Market Outlook, By Drug Type (2020-2028) ($MN)
- Table 41 North America Drug Discovery Market Outlook, By Large Molecule (2020-2028) ($MN)
- Table 42 North America Drug Discovery Market Outlook, By Small Molecule (2020-2028) ($MN)
- Table 43 North America Drug Discovery Market Outlook, By Technology (2020-2028) ($MN)
- Table 44 North America Drug Discovery Market Outlook, By Nanotechnology (2020-2028) ($MN)
- Table 45 North America Drug Discovery Market Outlook, By High Throughput Screening (2020-2028) ($MN)
- Table 46 North America Drug Discovery Market Outlook, By Combinatorial Chemistry (2020-2028) ($MN)
- Table 47 North America Drug Discovery Market Outlook, By Pharmacogenomics (2020-2028) ($MN)
- Table 48 North America Drug Discovery Market Outlook, By Bioanalytical Instruments (2020-2028) ($MN)
- Table 49 North America Drug Discovery Market Outlook, By Biochips (2020-2028) ($MN)
- Table 50 North America Drug Discovery Market Outlook, By Bioinformatics (2020-2028) ($MN)
- Table 51 North America Drug Discovery Market Outlook, By Other Technologies (2020-2028) ($MN)
- Table 52 North America Drug Discovery Market Outlook, By Service (2020-2028) ($MN)
- Table 53 North America Drug Discovery Market Outlook, By Medicinal Chemical Services (2020-2028) ($MN)
- Table 54 North America Drug Discovery Market Outlook, By Biological Services (2020-2028) ($MN)
- Table 55 North America Drug Discovery Market Outlook, By Drug Metabolism and Pharmacokinetics (DMPK) Services (2020-2028) ($MN)
- Table 56 North America Drug Discovery Market Outlook, By Other Services (2020-2028) ($MN)
- Table 57 North America Drug Discovery Market Outlook, By Process (2020-2028) ($MN)
- Table 58 North America Drug Discovery Market Outlook, By Target Selection (2020-2028) ($MN)
- Table 59 North America Drug Discovery Market Outlook, By Target Validation (2020-2028) ($MN)
- Table 60 North America Drug Discovery Market Outlook, By Hit-To-Lead Identification (2020-2028) ($MN)
- Table 61 North America Drug Discovery Market Outlook, By Lead Optimization (2020-2028) ($MN)
- Table 62 North America Drug Discovery Market Outlook, By Candidate Validation (2020-2028) ($MN)
- Table 63 North America Drug Discovery Market Outlook, By Therapeutic Area (2020-2028) ($MN)
- Table 64 North America Drug Discovery Market Outlook, By Respiratory Disease (2020-2028) ($MN)
- Table 65 North America Drug Discovery Market Outlook, By Neurology (2020-2028) ($MN)
- Table 66 North America Drug Discovery Market Outlook, By Infectious and Immune System Diseases (2020-2028) ($MN)
- Table 67 North America Drug Discovery Market Outlook, By Oncology (2020-2028) ($MN)
- Table 68 North America Drug Discovery Market Outlook, By Cardiovascular Diseases (2020-2028) ($MN)
- Table 69 North America Drug Discovery Market Outlook, By Digestive System Diseases (2020-2028) ($MN)
- Table 70 North America Drug Discovery Market Outlook, By Diabetes (2020-2028) ($MN)
- Table 71 North America Drug Discovery Market Outlook, By Other Therapeutic Areas (2020-2028) ($MN)
- Table 72 North America Drug Discovery Market Outlook, By End User (2020-2028) ($MN)
- Table 73 North America Drug Discovery Market Outlook, By Pharmaceutical Companies (2020-2028) ($MN)
- Table 74 North America Drug Discovery Market Outlook, By Contract Research Organization (CRO) (2020-2028) ($MN)
- Table 75 North America Drug Discovery Market Outlook, By Research Institutes (2020-2028) ($MN)
- Table 76 North America Drug Discovery Market Outlook, By Other End Users (2020-2028) ($MN)
- Table 77 Europe Drug Discovery Market Outlook, By Country (2020-2028) ($MN)
- Table 78 Europe Drug Discovery Market Outlook, By Drug Type (2020-2028) ($MN)
- Table 79 Europe Drug Discovery Market Outlook, By Large Molecule (2020-2028) ($MN)
- Table 80 Europe Drug Discovery Market Outlook, By Small Molecule (2020-2028) ($MN)
- Table 81 Europe Drug Discovery Market Outlook, By Technology (2020-2028) ($MN)
- Table 82 Europe Drug Discovery Market Outlook, By Nanotechnology (2020-2028) ($MN)
- Table 83 Europe Drug Discovery Market Outlook, By High Throughput Screening (2020-2028) ($MN)
- Table 84 Europe Drug Discovery Market Outlook, By Combinatorial Chemistry (2020-2028) ($MN)
- Table 85 Europe Drug Discovery Market Outlook, By Pharmacogenomics (2020-2028) ($MN)
- Table 86 Europe Drug Discovery Market Outlook, By Bioanalytical Instruments (2020-2028) ($MN)
- Table 87 Europe Drug Discovery Market Outlook, By Biochips (2020-2028) ($MN)
- Table 88 Europe Drug Discovery Market Outlook, By Bioinformatics (2020-2028) ($MN)
- Table 89 Europe Drug Discovery Market Outlook, By Other Technologies (2020-2028) ($MN)
- Table 90 Europe Drug Discovery Market Outlook, By Service (2020-2028) ($MN)
- Table 91 Europe Drug Discovery Market Outlook, By Medicinal Chemical Services (2020-2028) ($MN)
- Table 92 Europe Drug Discovery Market Outlook, By Biological Services (2020-2028) ($MN)
- Table 93 Europe Drug Discovery Market Outlook, By Drug Metabolism and Pharmacokinetics (DMPK) Services (2020-2028) ($MN)
- Table 94 Europe Drug Discovery Market Outlook, By Other Services (2020-2028) ($MN)
- Table 95 Europe Drug Discovery Market Outlook, By Process (2020-2028) ($MN)
- Table 96 Europe Drug Discovery Market Outlook, By Target Selection (2020-2028) ($MN)
- Table 97 Europe Drug Discovery Market Outlook, By Target Validation (2020-2028) ($MN)
- Table 98 Europe Drug Discovery Market Outlook, By Hit-To-Lead Identification (2020-2028) ($MN)
- Table 99 Europe Drug Discovery Market Outlook, By Lead Optimization (2020-2028) ($MN)
- Table 100 Europe Drug Discovery Market Outlook, By Candidate Validation (2020-2028) ($MN)
- Table 101 Europe Drug Discovery Market Outlook, By Therapeutic Area (2020-2028) ($MN)
- Table 102 Europe Drug Discovery Market Outlook, By Respiratory Disease (2020-2028) ($MN)
- Table 103 Europe Drug Discovery Market Outlook, By Neurology (2020-2028) ($MN)
- Table 104 Europe Drug Discovery Market Outlook, By Infectious and Immune System Diseases (2020-2028) ($MN)
- Table 105 Europe Drug Discovery Market Outlook, By Oncology (2020-2028) ($MN)
- Table 106 Europe Drug Discovery Market Outlook, By Cardiovascular Diseases (2020-2028) ($MN)
- Table 107 Europe Drug Discovery Market Outlook, By Digestive System Diseases (2020-2028) ($MN)
- Table 108 Europe Drug Discovery Market Outlook, By Diabetes (2020-2028) ($MN)
- Table 109 Europe Drug Discovery Market Outlook, By Other Therapeutic Areas (2020-2028) ($MN)
- Table 110 Europe Drug Discovery Market Outlook, By End User (2020-2028) ($MN)
- Table 111 Europe Drug Discovery Market Outlook, By Pharmaceutical Companies (2020-2028) ($MN)
- Table 112 Europe Drug Discovery Market Outlook, By Contract Research Organization (CRO) (2020-2028) ($MN)
- Table 113 Europe Drug Discovery Market Outlook, By Research Institutes (2020-2028) ($MN)
- Table 114 Europe Drug Discovery Market Outlook, By Other End Users (2020-2028) ($MN)
- Table 115 Asia Pacific Drug Discovery Market Outlook, By Country (2020-2028) ($MN)
- Table 116 Asia Pacific Drug Discovery Market Outlook, By Drug Type (2020-2028) ($MN)
- Table 117 Asia Pacific Drug Discovery Market Outlook, By Large Molecule (2020-2028) ($MN)
- Table 118 Asia Pacific Drug Discovery Market Outlook, By Small Molecule (2020-2028) ($MN)
- Table 119 Asia Pacific Drug Discovery Market Outlook, By Technology (2020-2028) ($MN)
- Table 120 Asia Pacific Drug Discovery Market Outlook, By Nanotechnology (2020-2028) ($MN)
- Table 121 Asia Pacific Drug Discovery Market Outlook, By High Throughput Screening (2020-2028) ($MN)
- Table 122 Asia Pacific Drug Discovery Market Outlook, By Combinatorial Chemistry (2020-2028) ($MN)
- Table 123 Asia Pacific Drug Discovery Market Outlook, By Pharmacogenomics (2020-2028) ($MN)
- Table 124 Asia Pacific Drug Discovery Market Outlook, By Bioanalytical Instruments (2020-2028) ($MN)
- Table 125 Asia Pacific Drug Discovery Market Outlook, By Biochips (2020-2028) ($MN)
- Table 126 Asia Pacific Drug Discovery Market Outlook, By Bioinformatics (2020-2028) ($MN)
- Table 127 Asia Pacific Drug Discovery Market Outlook, By Other Technologies (2020-2028) ($MN)
- Table 128 Asia Pacific Drug Discovery Market Outlook, By Service (2020-2028) ($MN)
- Table 129 Asia Pacific Drug Discovery Market Outlook, By Medicinal Chemical Services (2020-2028) ($MN)
- Table 130 Asia Pacific Drug Discovery Market Outlook, By Biological Services (2020-2028) ($MN)
- Table 131 Asia Pacific Drug Discovery Market Outlook, By Drug Metabolism and Pharmacokinetics (DMPK) Services (2020-2028) ($MN)
- Table 132 Asia Pacific Drug Discovery Market Outlook, By Other Services (2020-2028) ($MN)
- Table 133 Asia Pacific Drug Discovery Market Outlook, By Process (2020-2028) ($MN)
- Table 134 Asia Pacific Drug Discovery Market Outlook, By Target Selection (2020-2028) ($MN)
- Table 135 Asia Pacific Drug Discovery Market Outlook, By Target Validation (2020-2028) ($MN)
- Table 136 Asia Pacific Drug Discovery Market Outlook, By Hit-To-Lead Identification (2020-2028) ($MN)
- Table 137 Asia Pacific Drug Discovery Market Outlook, By Lead Optimization (2020-2028) ($MN)
- Table 138 Asia Pacific Drug Discovery Market Outlook, By Candidate Validation (2020-2028) ($MN)
- Table 139 Asia Pacific Drug Discovery Market Outlook, By Therapeutic Area (2020-2028) ($MN)
- Table 140 Asia Pacific Drug Discovery Market Outlook, By Respiratory Disease (2020-2028) ($MN)
- Table 141 Asia Pacific Drug Discovery Market Outlook, By Neurology (2020-2028) ($MN)
- Table 142 Asia Pacific Drug Discovery Market Outlook, By Infectious and Immune System Diseases (2020-2028) ($MN)
- Table 143 Asia Pacific Drug Discovery Market Outlook, By Oncology (2020-2028) ($MN)
- Table 144 Asia Pacific Drug Discovery Market Outlook, By Cardiovascular Diseases (2020-2028) ($MN)
- Table 145 Asia Pacific Drug Discovery Market Outlook, By Digestive System Diseases (2020-2028) ($MN)
- Table 146 Asia Pacific Drug Discovery Market Outlook, By Diabetes (2020-2028) ($MN)
- Table 147 Asia Pacific Drug Discovery Market Outlook, By Other Therapeutic Areas (2020-2028) ($MN)
- Table 148 Asia Pacific Drug Discovery Market Outlook, By End User (2020-2028) ($MN)
- Table 149 Asia Pacific Drug Discovery Market Outlook, By Pharmaceutical Companies (2020-2028) ($MN)
- Table 150 Asia Pacific Drug Discovery Market Outlook, By Contract Research Organization (CRO) (2020-2028) ($MN)
- Table 151 Asia Pacific Drug Discovery Market Outlook, By Research Institutes (2020-2028) ($MN)
- Table 152 Asia Pacific Drug Discovery Market Outlook, By Other End Users (2020-2028) ($MN)
- Table 153 South America Drug Discovery Market Outlook, By Country (2020-2028) ($MN)
- Table 154 South America Drug Discovery Market Outlook, By Drug Type (2020-2028) ($MN)
- Table 155 South America Drug Discovery Market Outlook, By Large Molecule (2020-2028) ($MN)
- Table 156 South America Drug Discovery Market Outlook, By Small Molecule (2020-2028) ($MN)
- Table 157 South America Drug Discovery Market Outlook, By Technology (2020-2028) ($MN)
- Table 158 South America Drug Discovery Market Outlook, By Nanotechnology (2020-2028) ($MN)
- Table 159 South America Drug Discovery Market Outlook, By High Throughput Screening (2020-2028) ($MN)
- Table 160 South America Drug Discovery Market Outlook, By Combinatorial Chemistry (2020-2028) ($MN)
- Table 161 South America Drug Discovery Market Outlook, By Pharmacogenomics (2020-2028) ($MN)
- Table 162 South America Drug Discovery Market Outlook, By Bioanalytical Instruments (2020-2028) ($MN)
- Table 163 South America Drug Discovery Market Outlook, By Biochips (2020-2028) ($MN)
- Table 164 South America Drug Discovery Market Outlook, By Bioinformatics (2020-2028) ($MN)
- Table 165 South America Drug Discovery Market Outlook, By Other Technologies (2020-2028) ($MN)
- Table 166 South America Drug Discovery Market Outlook, By Service (2020-2028) ($MN)
- Table 167 South America Drug Discovery Market Outlook, By Medicinal Chemical Services (2020-2028) ($MN)
- Table 168 South America Drug Discovery Market Outlook, By Biological Services (2020-2028) ($MN)
- Table 169 South America Drug Discovery Market Outlook, By Drug Metabolism and Pharmacokinetics (DMPK) Services (2020-2028) ($MN)
- Table 170 South America Drug Discovery Market Outlook, By Other Services (2020-2028) ($MN)
- Table 171 South America Drug Discovery Market Outlook, By Process (2020-2028) ($MN)
- Table 172 South America Drug Discovery Market Outlook, By Target Selection (2020-2028) ($MN)
- Table 173 South America Drug Discovery Market Outlook, By Target Validation (2020-2028) ($MN)
- Table 174 South America Drug Discovery Market Outlook, By Hit-To-Lead Identification (2020-2028) ($MN)
- Table 175 South America Drug Discovery Market Outlook, By Lead Optimization (2020-2028) ($MN)
- Table 176 South America Drug Discovery Market Outlook, By Candidate Validation (2020-2028) ($MN)
- Table 177 South America Drug Discovery Market Outlook, By Therapeutic Area (2020-2028) ($MN)
- Table 178 South America Drug Discovery Market Outlook, By Respiratory Disease (2020-2028) ($MN)
- Table 179 South America Drug Discovery Market Outlook, By Neurology (2020-2028) ($MN)
- Table 180 South America Drug Discovery Market Outlook, By Infectious and Immune System Diseases (2020-2028) ($MN)
- Table 181 South America Drug Discovery Market Outlook, By Oncology (2020-2028) ($MN)
- Table 182 South America Drug Discovery Market Outlook, By Cardiovascular Diseases (2020-2028) ($MN)
- Table 183 South America Drug Discovery Market Outlook, By Digestive System Diseases (2020-2028) ($MN)
- Table 184 South America Drug Discovery Market Outlook, By Diabetes (2020-2028) ($MN)
- Table 185 South America Drug Discovery Market Outlook, By Other Therapeutic Areas (2020-2028) ($MN)
- Table 186 South America Drug Discovery Market Outlook, By End User (2020-2028) ($MN)
- Table 187 South America Drug Discovery Market Outlook, By Pharmaceutical Companies (2020-2028) ($MN)
- Table 188 South America Drug Discovery Market Outlook, By Contract Research Organization (CRO) (2020-2028) ($MN)
- Table 189 South America Drug Discovery Market Outlook, By Research Institutes (2020-2028) ($MN)
- Table 190 South America Drug Discovery Market Outlook, By Other End Users (2020-2028) ($MN)
- Table 191 Middle East & Africa Drug Discovery Market Outlook, By Country (2020-2028) ($MN)
- Table 192 Middle East & Africa Drug Discovery Market Outlook, By Drug Type (2020-2028) ($MN)
- Table 193 Middle East & Africa Drug Discovery Market Outlook, By Large Molecule (2020-2028) ($MN)
- Table 194 Middle East & Africa Drug Discovery Market Outlook, By Small Molecule (2020-2028) ($MN)
- Table 195 Middle East & Africa Drug Discovery Market Outlook, By Technology (2020-2028) ($MN)
- Table 196 Middle East & Africa Drug Discovery Market Outlook, By Nanotechnology (2020-2028) ($MN)
- Table 197 Middle East & Africa Drug Discovery Market Outlook, By High Throughput Screening (2020-2028) ($MN)
- Table 198 Middle East & Africa Drug Discovery Market Outlook, By Combinatorial Chemistry (2020-2028) ($MN)
- Table 199 Middle East & Africa Drug Discovery Market Outlook, By Pharmacogenomics (2020-2028) ($MN)
- Table 200 Middle East & Africa Drug Discovery Market Outlook, By Bioanalytical Instruments (2020-2028) ($MN)
- Table 201 Middle East & Africa Drug Discovery Market Outlook, By Biochips (2020-2028) ($MN)
- Table 202 Middle East & Africa Drug Discovery Market Outlook, By Bioinformatics (2020-2028) ($MN)
- Table 203 Middle East & Africa Drug Discovery Market Outlook, By Other Technologies (2020-2028) ($MN)
- Table 204 Middle East & Africa Drug Discovery Market Outlook, By Service (2020-2028) ($MN)
- Table 205 Middle East & Africa Drug Discovery Market Outlook, By Medicinal Chemical Services (2020-2028) ($MN)
- Table 206 Middle East & Africa Drug Discovery Market Outlook, By Biological Services (2020-2028) ($MN)
- Table 207 Middle East & Africa Drug Discovery Market Outlook, By Drug Metabolism and Pharmacokinetics (DMPK) Services (2020-2028) ($MN)
- Table 208 Middle East & Africa Drug Discovery Market Outlook, By Other Services (2020-2028) ($MN)
- Table 209 Middle East & Africa Drug Discovery Market Outlook, By Process (2020-2028) ($MN)
- Table 210 Middle East & Africa Drug Discovery Market Outlook, By Target Selection (2020-2028) ($MN)
- Table 211 Middle East & Africa Drug Discovery Market Outlook, By Target Validation (2020-2028) ($MN)
- Table 212 Middle East & Africa Drug Discovery Market Outlook, By Hit-To-Lead Identification (2020-2028) ($MN)
- Table 213 Middle East & Africa Drug Discovery Market Outlook, By Lead Optimization (2020-2028) ($MN)
- Table 214 Middle East & Africa Drug Discovery Market Outlook, By Candidate Validation (2020-2028) ($MN)
- Table 215 Middle East & Africa Drug Discovery Market Outlook, By Therapeutic Area (2020-2028) ($MN)
- Table 216 Middle East & Africa Drug Discovery Market Outlook, By Respiratory Disease (2020-2028) ($MN)
- Table 217 Middle East & Africa Drug Discovery Market Outlook, By Neurology (2020-2028) ($MN)
- Table 218 Middle East & Africa Drug Discovery Market Outlook, By Infectious and Immune System Diseases (2020-2028) ($MN)
- Table 219 Middle East & Africa Drug Discovery Market Outlook, By Oncology (2020-2028) ($MN)
- Table 220 Middle East & Africa Drug Discovery Market Outlook, By Cardiovascular Diseases (2020-2028) ($MN)
- Table 221 Middle East & Africa Drug Discovery Market Outlook, By Digestive System Diseases (2020-2028) ($MN)
- Table 222 Middle East & Africa Drug Discovery Market Outlook, By Diabetes (2020-2028) ($MN)
- Table 223 Middle East & Africa Drug Discovery Market Outlook, By Other Therapeutic Areas (2020-2028) ($MN)
- Table 224 Middle East & Africa Drug Discovery Market Outlook, By End User (2020-2028) ($MN)
- Table 225 Middle East & Africa Drug Discovery Market Outlook, By Pharmaceutical Companies (2020-2028) ($MN)
- Table 226 Middle East & Africa Drug Discovery Market Outlook, By Contract Research Organization (CRO) (2020-2028) ($MN)
- Table 227 Middle East & Africa Drug Discovery Market Outlook, By Research Institutes (2020-2028) ($MN)
- Table 228 Middle East & Africa Drug Discovery Market Outlook, By Other End Users (2020-2028) ($MN)
